Dataset Information

Dataset for the synthesis and application of single-component heterogeneous catalysts based on zinc and tin for the cycloaddition of pure, diluted, and impure CO₂ to epoxides under mild conditions.

ABSTRACT: The cycloaddition of CO₂ to epoxides under mild conditions is a growing field of research and a viable strategy to recycle CO₂ in the form of cyclic carbonates as useful intermediates, solvents, and additives. This target requires readily accessible and recyclable catalysts whose synthesis does not involve expensive monomers, multistep procedures, coupling reagents, etc. Additionally, the catalysts should be active under atmospheric pressure and tolerate impurities such as methane and H₂S. In a recent manuscript (Rational engineering of single-component heterogeneous catalysts based on abundant metal centers for the mild conversion of pure and impure CO₂ to cyclic carbonates; Chemical Engineering Journal 422 (2021) 129930) we have developed strategies to prepare efficient heterogeneous catalysts for the cycloaddition reaction of CO₂ to epoxides. Such materials consist of dispersions of metal halides (ZnCl₂ or SnCl₄) on silica support that is further functionalized with ionic liquids bearing nucleophilic halide moieties for cooperative epoxide activation and ring-opening. Herein, we provide useful complementary data for the characterization of the prepared materials in the form of: SEM images of materials (SEM: scanning electron microscope), SEM-EDS images of materials (EDS: Energy-dispersive X-ray spectroscopy), TEM images of materials (TEM: transmission electron microscope); XPS (X-ray photoelectron spectroscopy) survey spectra of most active catalysts and related high-resolution spectra in spectral regions of interest, BET (Brunauer-Emmett-Teller) physisorption isotherms of materials, raw ¹H NMR spectra of catalytic reactions to verify the reproducibility of the reaction outcome and identify the reaction products.

SUBMITTER: Phungpanya C

PROVIDER: S-EPMC8192583 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundPlacebos play an important role in clinical trials and several surveys have shown that they are also common in daily practice. Previous research focused primarily on the frequency of placebo use in outpatient care. Our aim was to explore physicians' views on the use of placebos in daily practice, whereby distinction was made between pure placebos (substances with no pharmacological effect, e.g. sugar pills) and impure placebos (substances with pharmacological effect but not on the condition being treated, e.g. antibiotics in viral infections or vitamins).MethodsWe performed semi-structured interviews with a sample of twelve primary care physicians (PCPs). The interview addressed individual definitions of a placebo, attitudes towards placebos and the participants' reasons for prescribing them. The interviews were transcribed and analysed using qualitative content analysis.ResultsThe definition of a placebo given by the majority of the PCPs in our study was one which actually only describes pure placebos. This definition, combined with the fact that most impure placebos were not regarded as placebos at all, means that most of the participating PCPs were not aware of the extent to which placebos are used in daily practice. The PCPs stated that they use placebos (both pure and impure) mainly in the case of non-severe diseases for which there was often no satisfactory somatic explanation. According to the PCPs, cases like this are often treated by complementary and alternative therapies and these, too, are associated with placebo effects. However, all PCPs felt that the ethical aspects of such treatment were unclear and they were unsure as to how to communicate the use of placebos to their patients. Most of them would appreciate ethical guidelines on how to deal with this issue.ConclusionsMany PCPs seem to be unaware that some of the drugs they prescribe are classified as impure placebos. Perceptions of effectiveness and doubts about the legal and ethical aspects of the use of placebos by PCPs may discourage their application. Dissemination of guidelines and consensus papers may be one approach, but it has to be acknowledged that the topic itself is in conflict with the PCPs' perception of themselves as professional and reliable physicians.

Dataset Information

Dataset for the synthesis and application of single-component heterogeneous catalysts based on zinc and tin for the cycloaddition of pure, diluted, and impure CO₂ to epoxides under mild conditions.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Dataset Information

Dataset for the synthesis and application of single-component heterogeneous catalysts based on zinc and tin for the cycloaddition of pure, diluted, and impure CO2 to epoxides under mild conditions.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Dataset for the synthesis and application of single-component heterogeneous catalysts based on zinc and tin for the cycloaddition of pure, diluted, and impure CO₂ to epoxides under mild conditions.